Responses
Therapeutics
Randomised controlled trial
Cessation of donepezil is associated with clinical decline in patients with moderate-to-severe Alzheimer's disease compared to continuation of donepezil or addition or substitution of memantine
Compose a Response to This Article
Other responses
No responses have been published for this article.